INVO Fertility, Inc.
Datakwaliteit: 100%
IVF
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
€ 2,00
▼
€ 0,06
(-2,91%)
Marktkapitalisatie: 13,92 M
Prijs
€ 2,00
Marktkapitalisatie
13,92 M
Dagbereik
€ 1,93 — € 2,09
52-Weeksbereik
€ 1,93 — € 384,00
Volume
47.862
Openen € 2,06
50D / 200D Gem.
€ 4,67
57,21% below
50D / 200D Gem.
€ 32,59
93,86% below
Quick Summary
Belangrijkste Punten
Revenue grew 58,41% annually over 5 years — strong growth
Debt/Equity of 0,34 — conservative balance sheet
Negative free cash flow of -7,77 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 57,84%
Capital efficient — spends only 1,59% of revenue on capex
Groei
Revenue Growth (5Y)
58,41%
Boven sectorgemiddelde (9,35%)
Revenue (1Y)116,25%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-682,92%
Onder sectorgemiddelde (-51,02%)
ROIC-94,17%
Net Margin-417,01%
Op. Margin-141,14%
Veiligheid
Debt / Equity
0,34
Boven sectorgemiddelde (0,33)
Current Ratio0,12
Interest Coverage-10,81
Waardering
PE (TTM)
-0,48
Boven sectorgemiddelde (-1,98)
P/B Ratio2,38
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (44 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (44 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,5 | -2,0 |
| P/B | 2,4 | 5,1 |
| ROE % | -682,9 | -51,0 |
| Net Margin % | -417,0 | -150,2 |
| Rev Growth 5Y % | 58,4 | 9,3 |
| D/E | 0,3 | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 116,25% | Revenue Growth (3Y) | 181,86% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 58,41% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 6,94 M | Net Income (TTM) | -28,96 M |
| ROE | -682,92% | ROA | -151,80% |
| Gross Margin | N/A | Operating Margin | -141,14% |
| Net Margin | -417,01% | Free Cash Flow (TTM) | -7,77 M |
| ROIC | -94,17% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,34 | Current Ratio | 0,12 |
| Interest Coverage | -10,81 | Asset Turnover | 0,36 |
| Working Capital | -8,11 M | Tangible Book Value | -1,46 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,48 | Forward P/E | N/A |
| P/B Ratio | 2,38 | P/S Ratio | 2,00 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -55,79% | ||
| Market Cap | 13,92 M | Enterprise Value | 15,90 M |
| Per Share | |||
| EPS (Diluted TTM) | -46,38 | Revenue / Share | 1,00 |
| FCF / Share | -1,12 | OCF / Share | -1,10 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1,59% | FCF Conversion | 26,82% |
| SBC-Adj. FCF | N/A | Growth Momentum | 57,84 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 6,53 M | 3,02 M | 822.196,0 | 4,16 M | 1,04 M |
| Net Income | -9,10 M | -8,03 M | -10,89 M | -6,65 M | -8,35 M |
| EPS (Diluted) | -30,19 | -5,13 | -0,90 | -0,63 | -1,52 |
| Gross Profit | — | — | 490.673,0 | 4,02 M | 948.526,0 |
| Operating Income | -8,13 M | -6,77 M | -10,63 M | -5,22 M | -5,51 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 489.660,0 | 165.945,0 | 544.043,0 | 216.430,0 | 398.426,0 |
| SG&A Expenses | 9,08 M | 7,49 M | 10,57 M | 9,02 M | 6,07 M |
| D&A | 919.603,0 | 200.894,0 | 77.301,0 | 27.760,0 | 11.917,0 |
| Interest Expense | 1,06 M | 925.909,0 | 59.445,0 | 1,27 M | 2,84 M |
| Income Tax | -22.913,0 | 27.786,0 | 2.872,0 | 4.764,0 | 36,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 46,45 M | 20,89 M | 4,10 M | 10,47 M | 10,95 M |
| Total Liabilities | 26,24 M | 19,99 M | 5,08 M | 3,16 M | 5,20 M |
| Shareholders' Equity | 12,75 M | 892.825,0 | -977.612,0 | 7,31 M | 5,74 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | — | — | 5,68 M | 10,10 M |
| Current Assets | 1,32 M | 1,26 M | 621.087,0 | 6,31 M | 10,54 M |
| Current Liabilities | 17,93 M | 8,22 M | 3,41 M | 1,25 M | 2,29 M |
{"event":"ticker_viewed","properties":{"ticker":"IVF","listing_kind":"stock","pathname":"/stocks/ivf","exchange":"Nasdaq","country":"US"}}